Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 7.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 001498 | N. Fabre [France] ; C. Brefel-Courbon [France] ; O. Rascol [France] | Parkinson « plus » : Mouvements anormaux |
| 001948 | O. Rascol [France] ; U. Sabatini ; F. Chollet ; P. Celsis ; J.-L. Montastruc ; J.-P. Marc-Vergnes ; A. Rascol | Supplementary and primary sensory motor area activity in Parkinson's disease : regional cerebral blood flow changes during finger movements and effects of apomorphine |
| 001954 | A. Kastner [France] ; E. C. Hirsch ; O. Lejeune ; F. Javoy-Agid ; O. Rascol [France] ; Yves Agid [France] | Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content ? |
| 001A43 | J. L. Montastruc ; O. Rascol ; A. Rascol | Comparison de la bromocriptine et de la levodopa dans le traitement de première intention de la maladie de Parkinson : résultats à 3 ans d'une étude prospective randomisée |
| 001A62 | O. Rascol ; N. Fabre ; H. Teraêvaêinen ; Werner Poewe [Autriche] ; C. Luêcking ; U. Rinne ; E. Dupont ; D. Hirt ; M. Hoyer ; X. Lataste | CQA 206-291 : a novel dopamine agonist in the treatment of Parkinson's disease |
| 001B01 | O. Rascol ; M. Clanet ; J. L. Montastruc ; M. Simonetta ; M. J. Soulier-Esteve ; B. Doyon ; A. Rascol | Abnormal ocular movements in Parkinson's disease: evidence for involvement of dopaminergic systems |
| 001B21 | O. Rascol ; J. L. Montastruc ; J. M. Senard ; J. F. Demonet ; M. Simonetta ; A. Rascol | Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trial |
| This area was generated with Dilib version V0.6.29. |  |